These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 15939501

  • 1. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
    Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schöffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Esposito P, Huck C.
    J Control Release; 2005 Aug 18; 106(1-2):26-33. PubMed ID: 15939501
    [Abstract] [Full Text] [Related]

  • 2. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 3. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2006 Jan 13; 307(2):270-7. PubMed ID: 16300914
    [Abstract] [Full Text] [Related]

  • 4. Thiomers for oral delivery of hydrophilic macromolecular drugs.
    Bernkop-Schnürch A, Hoffer MH, Kafedjiiski K.
    Expert Opin Drug Deliv; 2004 Nov 13; 1(1):87-98. PubMed ID: 16296722
    [Abstract] [Full Text] [Related]

  • 5. In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan.
    Dünnhaupt S, Barthelmes J, Iqbal J, Perera G, Thurner CC, Friedl H, Bernkop-Schnürch A.
    J Control Release; 2012 Jun 28; 160(3):477-85. PubMed ID: 22542699
    [Abstract] [Full Text] [Related]

  • 6. Thiolated chitosans: useful excipients for oral drug delivery.
    Werle M, Bernkop-Schnürch A.
    J Pharm Pharmacol; 2008 Mar 28; 60(3):273-81. PubMed ID: 18284806
    [Abstract] [Full Text] [Related]

  • 7. Thiomers: potential excipients for non-invasive peptide delivery systems.
    Bernkop-Schnürch A, Krauland AH, Leitner VM, Palmberger T.
    Eur J Pharm Biopharm; 2004 Sep 28; 58(2):253-63. PubMed ID: 15296953
    [Abstract] [Full Text] [Related]

  • 8. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 28; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 9. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A.
    Biomaterials; 2006 Jan 28; 27(1):127-35. PubMed ID: 16045983
    [Abstract] [Full Text] [Related]

  • 10. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
    Senyigit ZA, Vetter A, Guneri T, Bernkop-Schnürch A.
    Drug Deliv; 2011 Aug 28; 18(6):405-14. PubMed ID: 21463156
    [Abstract] [Full Text] [Related]

  • 11. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF, Hombach J, Bernkop-Schnürch A.
    Int J Pharm; 2008 Feb 04; 348(1-2):54-60. PubMed ID: 17716840
    [Abstract] [Full Text] [Related]

  • 12. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F, Schmitz T, Bernkop-Schnürch A.
    Biomaterials; 2006 Aug 04; 27(23):4250-5. PubMed ID: 16618504
    [Abstract] [Full Text] [Related]

  • 13. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.
    Guggi D, Kast CE, Bernkop-Schnürch A.
    Pharm Res; 2003 Dec 04; 20(12):1989-94. PubMed ID: 14725364
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and in vitro evaluation of a novel thiolated chitosan.
    Kafedjiiski K, Krauland AH, Hoffer MH, Bernkop-Schnürch A.
    Biomaterials; 2005 Mar 04; 26(7):819-26. PubMed ID: 15350788
    [Abstract] [Full Text] [Related]

  • 15. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
    Bernkop-Schnürch A, Guggi D, Pinter Y.
    J Control Release; 2004 Jan 08; 94(1):177-86. PubMed ID: 14684281
    [Abstract] [Full Text] [Related]

  • 16. Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.
    Bernkop-Schnürch A, Krauland A, Valenta C.
    J Drug Target; 1998 Jan 08; 6(3):207-14. PubMed ID: 9888307
    [Abstract] [Full Text] [Related]

  • 17. Development and in vivo evaluation of an oral insulin-PEG delivery system.
    Calceti P, Salmaso S, Walker G, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2004 Jul 08; 22(4):315-23. PubMed ID: 15196588
    [Abstract] [Full Text] [Related]

  • 18. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system.
    Langoth N, Kahlbacher H, Schöffmann G, Schmerold I, Schuh M, Franz S, Kurka P, Bernkop-Schnürch A.
    Pharm Res; 2006 Mar 08; 23(3):573-9. PubMed ID: 16411147
    [Abstract] [Full Text] [Related]

  • 19. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L, Ding J, He C, Cui L, Tang C, Yin C.
    Biomaterials; 2009 Oct 08; 30(29):5691-700. PubMed ID: 19615735
    [Abstract] [Full Text] [Related]

  • 20. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, Yoo MK, Lee HG, Cho CS.
    Int J Pharm; 2008 Jul 09; 359(1-2):205-10. PubMed ID: 18490120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.